HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 129 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,539 | -62.2% | 2,334 | -73.2% | 0.00% | – |
| Q2 2023 | $104,496 | -54.2% | 8,708 | -50.2% | 0.00% | – |
| Q1 2023 | $228,000 | +66958.8% | 17,499 | -23.9% | 0.00% | – |
| Q4 2022 | $340 | -100.0% | 23,002 | -91.1% | 0.00% | – |
| Q3 2022 | $2,291,000 | -36.3% | 258,705 | -9.0% | 0.00% | -100.0% |
| Q2 2022 | $3,594,000 | -54.1% | 284,329 | -31.2% | 0.00% | 0.0% |
| Q1 2022 | $7,822,000 | -85.2% | 413,449 | -72.6% | 0.00% | -83.3% |
| Q4 2021 | $52,964,000 | -13.5% | 1,509,833 | -9.7% | 0.01% | -25.0% |
| Q3 2021 | $61,241,000 | -29.8% | 1,672,778 | -24.7% | 0.01% | -20.0% |
| Q2 2021 | $87,293,000 | +38.9% | 2,222,937 | -0.1% | 0.01% | +25.0% |
| Q1 2021 | $62,829,000 | +32.0% | 2,224,066 | +49.6% | 0.01% | +14.3% |
| Q4 2020 | $47,589,000 | +5.4% | 1,486,229 | +4.5% | 0.01% | -12.5% |
| Q3 2020 | $45,134,000 | +24.2% | 1,421,554 | +7.9% | 0.01% | +14.3% |
| Q2 2020 | $36,345,000 | +77.5% | 1,317,832 | +14.9% | 0.01% | +40.0% |
| Q1 2020 | $20,479,000 | -6.7% | 1,147,267 | +31.1% | 0.01% | +25.0% |
| Q4 2019 | $21,939,000 | +49.4% | 875,105 | +6.3% | 0.00% | +33.3% |
| Q3 2019 | $14,686,000 | -8.1% | 823,300 | +55.5% | 0.00% | 0.0% |
| Q2 2019 | $15,988,000 | -21.2% | 529,386 | -20.2% | 0.00% | -25.0% |
| Q1 2019 | $20,293,000 | +44.7% | 663,615 | +9.3% | 0.00% | +33.3% |
| Q4 2018 | $14,024,000 | -66.2% | 607,327 | -52.8% | 0.00% | -62.5% |
| Q3 2018 | $41,462,000 | -13.2% | 1,288,073 | -18.8% | 0.01% | -20.0% |
| Q2 2018 | $47,794,000 | +5.8% | 1,585,723 | +3.8% | 0.01% | 0.0% |
| Q1 2018 | $45,159,000 | -8.6% | 1,527,742 | +21.9% | 0.01% | 0.0% |
| Q4 2017 | $49,397,000 | +347.8% | 1,253,084 | +209.4% | 0.01% | +400.0% |
| Q3 2017 | $11,032,000 | +116.2% | 404,996 | +85.1% | 0.00% | +100.0% |
| Q2 2017 | $5,102,000 | – | 218,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Zeal Asset Management Ltd | 2,339,885 | $93,421,000 | 21.31% |
| UG Investment Advisers Ltd. | 33,155 | $1,302,000 | 2.52% |
| Pinz Capital Management, LP | 159,400 | $6,260,000 | 1.88% |
| Capital International Sarl | 547,743 | $21,510,000 | 1.86% |
| Capital International, Inc./CA/ | 4,391,684 | $172,461,000 | 1.54% |
| AIA Group Ltd | 437,118 | $17,380,000 | 1.20% |
| York Capital Management Global Advisors, LLC | 182,297 | $7,159,000 | 0.80% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 68,000 | $2,671,000 | 0.70% |
| E Fund Management (Hong Kong) Co., Ltd. | 18,579 | $730,000 | 0.46% |
| M&G INVESTMENT MANAGEMENT LTD | 4,512,562 | $175,990,000 | 0.44% |